MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
![Foto de MARÍA JOSÉ](/img/nophoto.png)
![Foto de Istituto Superiore di Sanità](/img/noimage_org.png)
Istituto Superiore di Sanità
Roma, ItaliaPublicaciones en colaboración con investigadores/as de Istituto Superiore di Sanità (74)
2024
-
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307
2023
-
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Frontiers in Oncology, Vol. 13
2022
-
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials
Frontiers in Oncology, Vol. 12
2020
-
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602
2019
-
Epidemiology of rare cancers and inequalities in oncologic outcomes
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 3-11
-
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 75-80
-
Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 60-66
-
Treatment challenges in and outside a network setting: Head and neck cancers
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 40-45
-
Treatment challenges in and outside a network setting: Soft tissue sarcomas
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 31-39
-
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
European Journal of Surgical Oncology, Vol. 45, Núm. 1, pp. 46-51
2018
-
Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
European Journal of Cancer, Vol. 93, pp. 127-137
2017
-
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039
-
Data quality in rare cancers registraton: The report of the RARECARE data quality study
Tumori, Vol. 103, Núm. 1, pp. 22-32
-
Geographical variability in survival of European children with central nervous system tumours
European Journal of Cancer, Vol. 82, pp. 137-148
-
New insights into survival trend analyses in cancer population-based studies: The SUDCAN methodology
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S9-S15
-
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
European Journal of Cancer, Vol. 84, pp. 335-353
-
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
European Journal of Cancer, Vol. 77, pp. 140-152
-
Trends in net survival from 15 cancers in six European Latin countries: The SUDCAN population-based study material
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S3-S8
-
Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S85-S91
-
Trends in net survival from cervical cancer in six European Latin countries: Results from the SUDCAN population-based study
European Journal of Cancer Prevention, Vol. 26, Núm. Trends in cancer net survival in six European Latin Countries: the SUDCAN study, pp. S92-S99